Webinar | January 7, 2021

Regulatory Approval For Bayesian Clinical Trials

Source: Cytel

Clinical trials designed using Bayesian statistics are gaining prominence due to challenges raised by coronavirus. Former FDA Director of Biostatistics, Gregory Campbell, discusses best practices for securing regulatory approval when submitting a trial that employs Bayesian clinical trial design.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: